ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 17551 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 17551; 2) Community: the network communities that were significantly associated with the response to NSC 17551; 3) Molecule: the relationships between components within communities and NSC 17551; 4) MDR: the compounds that were significantly associated with the NSC 17551.

NSC Compound Enrichment Correlation
NSC 654236 Null 0.0107933723273943 0.043029112
NSC 672425 1,2-Benzo-8-(L-alanyl)-3-phenoxazone nitrate salt 0.0107933723273943 -0.14827498
NSC 684836 Butanamide, N-[2-[(4-fluorophenyl)amino]-1,1,1,3,3,3- hexafluoro-2-propyl]- 0.0107933723273943 0.16892938
NSC 733906 Null 0.0107933723273943 0.17902803
NSC 757949 (1R,2E,6R,10E,11aS,13S,14aR)-6-(2-(benzyloxy)ethyl)-1,13-dihydroxy-6,7,8,9,12,13,14,14a-octahydro-1H-cyclopenta[f][1]oxacyclotridecin-4(11aH)-one 0.0107933723273943 -0.33302667
NSC 763646 (E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole 0.0107933723273943 0.27838813
NSC 79563 1,3-bis(4-chlorobenzyl)-2-(phenanthren-9-yl)hexahydropyrimidine 0.0107933723273943 -0.12571875
NSC 266748 Hydrazinecarbothioamide, 2-[[3-(methylamino)-2-pyridinyl]methylene]- 0.0110679092462694 0.09563137
NSC 287459 Cytarabine AY 0.0110679092462694 0.39491449
NSC 329127 Null 0.0110679092462694 0.047076628
Total:60  Current:11    [First] [Prev] [Next] [Last]